Effects of growth hormone on cognitive function.

Area of Science:

• Pediatric Endocrinology
• Neuroendocrinology
• Genetics

Background:

• Growth hormone deficiency (GHD) and Turner syndrome (TS) can impact cognitive function and quality of life (QoL).
• Previous research on the effects of GH treatment on cognition in GHD and TS is controversial.
• Limited data exist on QoL in children with GHD and the specific neurocognitive profile of TS.

Purpose of the Study:

• To evaluate the effects of GH treatment on neurocognitive function in girls with TS.
• To assess the role of GH treatment in addressing characteristic nonverbal neurocognitive deficits in TS.

Main Methods:

• A long-term, double-blind, placebo-controlled trial.
• Inclusion of girls with TS enrolled in a trial for GH treatment effects on final adult height.
• Treatment duration varied from 1 to 7 years.

Main Results:

• GH treatment showed no significant effect on cognitive function in girls with TS.
• The study did not support a role for GH in influencing the nonverbal neurocognitive deficits associated with TS.
• Cognitive and QoL outcomes in GHD and TS are influenced by GH treatment in some, but not all, studies.

Conclusions:

• GH treatment does not appear to influence cognitive function in girls with TS.
• Quality of life (QoL) evaluation should be integrated into routine clinical management for patients with GHD or TS.
• Further research may be needed to fully understand the complex interplay between GH, cognition, and QoL in these conditions.